Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

OBJECTIVE: This 1-year study aimed to assess low-dose budesonide therapy for maintenance of clinical remission in patients with collagenous colitis. DESIGN: A prospective, randomised, placebo-controlled study beginning with an 8-week open-label induction phase in which patients with histologically c...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Gut
Huvudupphovsmän: Münch, Andreas, Bohr, Johan, Miehlke, Stephan, Benoni, Cecilia, Olesen, Martin, Öst, Åke, Strandberg, Lars, Hellström, Per M, Hertervig, Erik, Armerding, Peter, Stehlik, Jiri, Lindberg, Greger, Björk, Jan, Lapidus, Annika, Löfberg, Robert, Bonderup, Ole, Avnström, Sören, Rössle, Martin, Dilger, Karin, Mueller, Ralph, Greinwald, Roland, Tysk, Curt, Ström, Magnus
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2016
Ämnen:
Inflammatory Bowel Disease
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4717436/
https://ncbi.nlm.nih.gov/pubmed/25425655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2014-308363
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk